Advanced search
1 file | 334.60 KB Add to list

Pilot study on patients with Mal de Debarquement syndrome during pregnancy

Author
Organization
Abstract
Aim: To evaluate if patients with Mal de Debarquement syndrome (MdDS) demonstrate different symptom levels or symptom type during pregnancy. Materials & methods: 18 MdDS patients that were or had been pregnant during their condition were recruited to complete a retrospective online questionnaire. Respondents answered questions regarding their basic clinical data, diagnosis, triggers and differences in symptom level and symptom type during pregnancy and before pregnancy. Results: A total of 81.3% reported that their symptoms were reduced during pregnancy compared with before pregnancy. Respondents also reported a different perception of motion and experienced less dizziness while being pregnant. Conclusion: The physiological changes that occur during pregnancy improve the symptoms of patients with MdDS, and this is potentially attributable to the rise in estrogen and progesterone. Lay abstract: Mal de Debarquement syndrome (MdDS) is a rare neurological disorder characterized by a constant sensation of self-motion. More women are affected than men, and subsequently a hormonal implication has been theorized. This study aimed to evaluate if symptoms change in patients with MdDS during their pregnancy. A total of 18 MdDS patients were recruited to complete a retrospective online questionnaire. Among these, 81.3% of respondents reported that their symptoms were lower during pregnancy compared with before pregnancy. Respondents also reported a different perception of motion and experienced less dizziness while being pregnant. Our results support the hypothesis that pregnancy positively influences MdDS symptoms.
Keywords
estrogen, Mal de Debarquement syndrome (MdDS), MdDS symptoms, pregnancy, ALLOPREGNANOLONE LEVELS, VESTIBULOOCULAR REFLEX, WOMEN, MIGRAINE, ESTROGEN, BRAIN, PLASTICITY, SYMPTOMS

Downloads

  • MdDS and pregnancy.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 334.60 KB

Citation

Please use this url to cite or link to this publication:

MLA
Mucci, Viviana, et al. “Pilot Study on Patients with Mal de Debarquement Syndrome during Pregnancy.” FUTURE SCIENCE OA, vol. 5, no. 4, 2019, doi:10.4155/fsoa-2018-0109.
APA
Mucci, V., Canceri, J., Jacquemyn, Y., Van Ombergen, A., Maes, L., Van de Heyning, P., & Browne, C. (2019). Pilot study on patients with Mal de Debarquement syndrome during pregnancy. FUTURE SCIENCE OA, 5(4). https://doi.org/10.4155/fsoa-2018-0109
Chicago author-date
Mucci, Viviana, Josephine Canceri, Yves Jacquemyn, Angelique Van Ombergen, Leen Maes, Paul Van de Heyning, and Cherylea Browne. 2019. “Pilot Study on Patients with Mal de Debarquement Syndrome during Pregnancy.” FUTURE SCIENCE OA 5 (4). https://doi.org/10.4155/fsoa-2018-0109.
Chicago author-date (all authors)
Mucci, Viviana, Josephine Canceri, Yves Jacquemyn, Angelique Van Ombergen, Leen Maes, Paul Van de Heyning, and Cherylea Browne. 2019. “Pilot Study on Patients with Mal de Debarquement Syndrome during Pregnancy.” FUTURE SCIENCE OA 5 (4). doi:10.4155/fsoa-2018-0109.
Vancouver
1.
Mucci V, Canceri J, Jacquemyn Y, Van Ombergen A, Maes L, Van de Heyning P, et al. Pilot study on patients with Mal de Debarquement syndrome during pregnancy. FUTURE SCIENCE OA. 2019;5(4).
IEEE
[1]
V. Mucci et al., “Pilot study on patients with Mal de Debarquement syndrome during pregnancy,” FUTURE SCIENCE OA, vol. 5, no. 4, 2019.
@article{8604043,
  abstract     = {Aim: To evaluate if patients with Mal de Debarquement syndrome (MdDS) demonstrate different symptom levels or symptom type during pregnancy. Materials & methods: 18 MdDS patients that were or had been pregnant during their condition were recruited to complete a retrospective online questionnaire. Respondents answered questions regarding their basic clinical data, diagnosis, triggers and differences in symptom level and symptom type during pregnancy and before pregnancy. Results: A total of 81.3% reported that their symptoms were reduced during pregnancy compared with before pregnancy. Respondents also reported a different perception of motion and experienced less dizziness while being pregnant. Conclusion: The physiological changes that occur during pregnancy improve the symptoms of patients with MdDS, and this is potentially attributable to the rise in estrogen and progesterone.

Lay abstract: Mal de Debarquement syndrome (MdDS) is a rare neurological disorder characterized by a constant sensation of self-motion. More women are affected than men, and subsequently a hormonal implication has been theorized. This study aimed to evaluate if symptoms change in patients with MdDS during their pregnancy. A total of 18 MdDS patients were recruited to complete a retrospective online questionnaire. Among these, 81.3% of respondents reported that their symptoms were lower during pregnancy compared with before pregnancy. Respondents also reported a different perception of motion and experienced less dizziness while being pregnant. Our results support the hypothesis that pregnancy positively influences MdDS symptoms.},
  articleno    = {FSO377},
  author       = {Mucci, Viviana and Canceri, Josephine and Jacquemyn, Yves and Van Ombergen, Angelique and Maes, Leen and Van de Heyning, Paul and Browne, Cherylea},
  issn         = {2056-5623},
  journal      = {FUTURE SCIENCE OA},
  keywords     = {estrogen,Mal de Debarquement syndrome (MdDS),MdDS symptoms,pregnancy,ALLOPREGNANOLONE LEVELS,VESTIBULOOCULAR REFLEX,WOMEN,MIGRAINE,ESTROGEN,BRAIN,PLASTICITY,SYMPTOMS},
  language     = {eng},
  number       = {4},
  pages        = {12},
  title        = {Pilot study on patients with Mal de Debarquement syndrome during pregnancy},
  url          = {http://dx.doi.org/10.4155/fsoa-2018-0109},
  volume       = {5},
  year         = {2019},
}

Altmetric
View in Altmetric